CAPTIVATE study: outcomes in patients with uMRD following cessation of ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:34 1 year ago 107 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
Long Term Follow-Up With Ibrutinib + Venetoclax to Treat Chronic Lymphocytic Leukemia CheckRare 5:29 1 year ago 806 Далее Скачать
Exploratory analysis of the CLARITY study: ibrutinib plus venetoclax in patients with R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 173 Далее Скачать
Ibrutinib plus venetoclax for first-line treatment of CLL: 4-year follow-up data VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 485 Далее Скачать
CAPTIVATE: ibrutinib/venetoclax delivers high rates of uMRD in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:04 5 years ago 436 Далее Скачать
Ibrutinib plus venetoclax for the first-line treatment of CLL/SLL: Results from the CAPTIVATE study ecancer 4:04 4 years ago 175 Далее Скачать
CAPTIVATE: Ibrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:21 2 years ago 371 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
Interim analysis of the FLAIR study: efficacy of ibrutinib plus venetoclax in IgHV unmutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 1 year ago 328 Далее Скачать
Outcomes for CLL Patients After Treatment With Ibrutinib Plus Venetoclax - Dr. John Allan ASH 2022 CLL Society 12:05 1 year ago 207 Далее Скачать
Update on the CAPTIVATE Study for Chronic Lymphocytic Leukemia Patients CheckRare 3:49 4 years ago 178 Далее Скачать
First-line ibrutinib and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:18 2 years ago 350 Далее Скачать
Five-year follow-up of the CAPTIVATE trial: ibrutinib retreatment in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:00 10 months ago 228 Далее Скачать
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia ecancer 6:55 3 years ago 377 Далее Скачать
CAPTIVATE: 1-year DFS results from the MRD cohort in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:17 4 years ago 106 Далее Скачать
Updates from CAPTIVATE: ibrutinib and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:54 4 years ago 494 Далее Скачать
Achieving undetectable MRD with ibrutinib plus venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:53 3 years ago 219 Далее Скачать
Frontline ibrutinib + venetoclax in CLL: Results from a fixed duration cohort of the CAPTIVATE study Lymphoma Hub 4:45 3 years ago 108 Далее Скачать
